Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Last Close
Dec 05 04:00PM ET
Dollar change
Percentage change
Index- P/E- EPS (ttm)-0.83 Insider Own27.79% Shs Outstand111.58M Perf Week-9.14%
Market Cap65.89M Forward P/E- EPS next Y-0.61 Insider Trans0.11% Shs Float80.56M Perf Month-16.85%
Income-61.09M PEG- EPS next Q-0.16 Inst Own63.74% Short Float / Ratio2.30% / 5.05 Perf Quarter-40.95%
Sales0.00M P/S- EPS this Y40.06% Inst Trans0.66% Short Interest1.85M Perf Half Y-62.39%
Book/sh0.85 P/B0.70 EPS next Y0.45% ROA-72.08% Target Price6.67 Perf Year-3.20%
Cash/sh0.93 P/C0.63 EPS next 5Y- ROE-86.23% 52W Range0.39 - 3.80 Perf YTD22.28%
Dividend- P/FCF- EPS past 5Y- ROI-63.51% 52W High-84.46% Beta1.92
Dividend %- Quick Ratio8.84 Sales past 5Y0.00% Gross Margin- 52W Low52.90% ATR0.07
Employees35 Current Ratio8.84 Sales Q/Q- Oper. Margin0.00% RSI (14)38.64 Volatility11.64% 10.39%
OptionableYes Debt/Eq0.03 EPS Q/Q50.71% Profit Margin- Rel Volume0.40 Prev Close0.60
ShortableYes LT Debt/Eq0.02 EarningsNov 09 BMO Payout- Avg Volume366.23K Price0.59
Recom1.25 SMA20-10.69% SMA50-17.72% SMA200-54.23% Volume145,374 Change-1.52%
Date Action Analyst Rating Change Price Target Change
Aug-11-23Initiated CapitalOne Overweight $7
Feb-28-22Initiated Cantor Fitzgerald Overweight $10
Nov-08-21Initiated Credit Suisse Outperform $15
Oct-21-21Initiated William Blair Outperform
Oct-20-21Initiated BMO Capital Markets Outperform $19
Oct-13-21Initiated Oppenheimer Outperform $21
Nov-30-23 08:00AM
Nov-09-23 09:48AM
Nov-08-23 04:30PM
Nov-02-23 09:00AM
08:00AM Loading…
Nov-01-23 08:00AM
Oct-09-23 08:30AM
Sep-25-23 08:00AM
Sep-21-23 08:00AM
Sep-15-23 08:00AM
Aug-11-23 04:05PM
Aug-04-23 04:51PM
Aug-02-23 08:00AM
Jun-22-23 08:00AM
08:00AM Loading…
Jun-20-23 08:00AM
Jun-13-23 08:00AM
May-12-23 04:05PM
May-10-23 08:00AM
Apr-13-23 08:00AM
Apr-10-23 04:05PM
Mar-31-23 08:00AM
Mar-23-23 08:00AM
Mar-09-23 08:00AM
Mar-08-23 04:05PM
Feb-17-23 08:20AM
Feb-16-23 04:05PM
Feb-03-23 04:05PM
08:00AM Loading…
Jan-30-23 08:00AM
Jan-27-23 01:10PM
Jan-25-23 08:00AM
Jan-24-23 04:25PM
Jan-13-23 08:00AM
Jan-10-23 08:00AM
Jan-04-23 08:00AM
Jan-03-23 08:00AM
Nov-10-22 04:05PM
Sep-26-22 08:00AM
Sep-23-22 08:00AM
Sep-15-22 08:00AM
Aug-12-22 04:05PM
Jun-23-22 04:05PM
Jun-20-22 10:59AM
Jun-07-22 08:00AM
Jun-06-22 08:00AM
May-27-22 08:00AM
May-17-22 08:00AM
May-12-22 04:05PM
Apr-28-22 08:00AM
Apr-26-22 04:05PM
Apr-22-22 08:00AM
Mar-31-22 08:00AM
Mar-25-22 07:30PM
Mar-21-22 08:30AM
Mar-18-22 04:05PM
Mar-10-22 08:00AM
Feb-28-22 08:00AM
Feb-24-22 05:19PM
Feb-02-22 01:38PM
Dec-08-21 11:15AM
Nov-20-21 08:21AM
Nov-12-21 04:05PM
Nov-09-21 08:00AM
Nov-08-21 08:00AM
Oct-15-21 09:39PM
Jasper Therapeutics, Inc. is a clinical-stage biotechnology company, which engages in enabling cures through hematopoietic stem cell therapy. It focuses on the development and commercialization of safer, stem cell engineering to allow for expanded use of stem cell transplantation and ex vivo gene therapy, a technique in which genetic manipulation of cells is performed outside of the body prior to transplantation. The company was founded by Judith Shizuru and Susan Prohaska in March 2018 and is headquartered in Redwood City, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
WIGGANS THOMAS GDirectorNov 28Buy0.6510,0006,48650,000Nov 30 04:05 PM
WIGGANS THOMAS GDirectorNov 21Buy0.6410,0006,38340,000Nov 22 04:06 PM
WIGGANS THOMAS GDirectorNov 20Buy0.6310,0006,30930,000Nov 20 08:14 PM
WIGGANS THOMAS GDirectorNov 17Buy0.6010,0005,96620,000Nov 20 08:14 PM
WIGGANS THOMAS GDirectorNov 16Buy0.6010,0005,96510,000Nov 20 08:14 PM
Lis WilliamDirectorOct 13Sale0.857,9656,77753,521Oct 13 06:56 PM
Mahal Jeetinder SinghSee RemarksJun 13Option Exercise0.719,0006,390296,223Jun 13 08:54 PM
Mahal Jeetinder SinghSee RemarksJun 13Sale1.669,00014,915287,223Jun 13 08:54 PM
French Anna LouiseDirectorApr 14Sale1.487,00010,36023,750Apr 14 04:19 PM
EMSTER KURT VONDirectorApr 13Sale1.499,07513,52421,175Apr 14 04:19 PM
Lis WilliamDirectorApr 13Sale1.448,50012,24061,486Apr 14 04:14 PM
Carlyle Group Inc.10% OwnerJan 27Buy1.503,133,3334,700,0008,761,891Jan 31 05:24 PM
Qiming U.S. Healthcare Fund II10% OwnerJan 27Buy1.502,666,6663,999,9998,519,648Apr 11 07:55 PM
ROCHE HOLDING LTD10% OwnerJan 25Sale1.8975,000141,7504,549,606Jan 26 05:49 PM